Douglas Pharms Company Profile
What is the competitive landscape for DOUGLAS PHARMS
DOUGLAS PHARMS has one approved drug.
There is one US patent protecting DOUGLAS PHARMS drugs.
Summary for Douglas Pharms
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Douglas Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Douglas Pharms | VERSACLOZ | clozapine | SUSPENSION;ORAL | 203479-001 | Feb 6, 2013 | RX | Yes | Yes | 8,057,811 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Douglas Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2436213 | ⤷ Start Trial |
| New Zealand | 527142 | ⤷ Start Trial |
| European Patent Office | 1646393 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2005007168 | ⤷ Start Trial |
| Canada | 2532648 | ⤷ Start Trial |
| Australia | 2004257556 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
